Bio Elpida is a Contract Manufacturing Organisation (CMO) based in Lyon - France, which applies single-use bioprocessing for development and manufacturing of biological and cell-based products.
Bio Elpida’s scientists have long experience optimising, culturing and expanding many types of primary cells, including:
Mensenchymal and other adult stem cells
Lymphocytes (T-cells, CD4, CD8, ...)
Bio Elpida’s scientists have also deep expertise in assay pharmaceutical development, formulation, analytical and quality assurance work.
Bio Elpida can process autologous, allogenic material or tissue from various sources such as tumors, whole blood, bone marrow or cord blood.
Bio Elpida staff is well-versed in the quidelines of current Good Manufacturing Procedures (cGMP - see 21CFR210-211), in particular as they apply to the manufacture of biologic agents (see 21CFR600-680), as well as Good Tissue Practices (GTP - see 21CFR12